Filing Details
- Accession Number:
- 0001209191-14-013598
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2014-02-24 17:31:28
- Reporting Period:
- 2014-02-20
- Filing Date:
- 2014-02-24
- Accepted Time:
- 2014-02-24 17:31:28
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1373707 | Tetraphase Pharmaceuticals Inc | TTPH | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1572339 | A. Joyce Sutcliffe | 480 Arsenal St. Suite 110 Watertown MA 02472 | Senior Vice President, Biology | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2014-02-20 | 11,494 | $14.00 | 28,736 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 17, 2013.
- The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $13.92 to $14.14 per share. The reporting person hereby undertakes, upon request of the staff of the U.S. Securities and Exchange Commission, the issuer, or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price
Billionaire Hedge Funds
